Thyroid dysfunction and pregnancy: common grounds, the mechanisms of realization, management tactics.

Thyroid dysfunction and pregnancy: common grounds, the mechanisms of realization, management tactics.

PHD O.Yu. Zhelezniakov, PHD N.M. Zhelezniakova. Kharkiv Medical Academy of Postgraduate Education.

This article discusses the changes in thyroid physiology that occur during pregnancy, the significance of thyroid function tests and thyroid antibody titers assessed during pregnancy, and the potential obstetric complications associated with maternal hypothyroidism. Also discussed the tactics of management of this category of pregnant women.

Key Words: hypothyroidism, pregnancy, thyroid antibodies, management tactics.

Zhelezniakov OYu, Zhelezniakova NM. [Thyroid dysfunction and pregnancy: common grounds, the mechanisms of realization, management tactics]. Shidnoevr. z. vnutr. simejnoi med. 2014;1:56-60. Russian.


Test «Thyroid dysfunction and pregnancy: common grounds, the mechanisms of realization, management tactics».

1. Abalovich M. [Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline]. I Clin Endocrinol Metab. 2007; 92 (8): 1—47. English
2. Abbassi-Ghanavati M. [Pregnancy outcomes in women with thyroid peroxidase antibodies]. Obstet Gynecol. 2010; 116(2): 381. English
3. Ain KB. [Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen-induced elevation of serum TBG concentration]. I Clin Endocrinol Metab. 1987; 65(4): 689—696. English
4. Allan WC. [Maternal thyroid deficiency and pregnancy complications: implications for population screening]. I Med Screen. 2000; 7(3):127—130. English
5. Bagis T. [Autoimmune thyroid disease in pregnancy and the postpartum period: relationship to spontaneous abortion]. Thyroid. 2001; 11(11): 1049—1053. English
6. Brown RS. [Minireview: developmental regulation of thyrotropin receptor gene expression in the fetal and newborn thyroid]. Endocrinology. 2004; 145(9): 4058—4061. English
7. Bussen S. [Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions]. Hum Reprod.1995; 10 (11): 2938—2940. English
8. Casey BM. [Subclinical hypothyroidism and pregnancy outcomes]. Obstet Gynecol. 2005; 105(2): 239—245. English
9. Carolis DC. [Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters]. Am I Reprod Immunol. 2004; 52(4): 263—266. English
10. Vivo DA. [Thyroid function in women found to have early pregnancy loss]. Thyroid. 2010; 20(6): 633—637. English
11. Fisher DA. [Fetal thyroid function: diagnosis and management of fetal thyroid disorders]. Clin Obstet Gynecol.1997; 40 (1):16—31. English
12. Glinoer D. [Regulation of maternal thyroid during pregnancy]. I Clin Endocrinol Metab. 1990; 71(2): 276—87. English
13. Glinoer D. [Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders]. I Clin Endocrinol Metab.1994; 9(1): 197—204. English
14. Glinoer D. [Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions]. I Clin Endocrinol Metab.1991; 73(2): 421—427. English
15. Glinoer D. [The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology]. Endocr Rev.1997;18 (3): 404—433. English
16. Grun IP. [The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies]. Clin Endocrinol (Oxf).1997;46(6): 719—725. English
17. Hollowell IG. [T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)]. I Clin Endocrinol Metab. 2002; 87(2): 489—499. English
18. Iiima T. [Effects of autoantibodies on the course of pregnancy and fetal growth]. Obstet Gynecol. 1997; 90(3): 364—369. English
19. Klein RZ. [Prevalence of thyroid deficiency in pregnant women]. Clin Endocrinol (Oxf).1991; 35 (1): 41—6. English
20. Kuppens SM. [Maternal thyroid function during gestation is related to breech presentation at term]. Clin Endocrinol (Oxf). 2010; 72: 820—824. English
21. Lee RH. [Free T4 immunoassays are flawed during pregnancy]. Am I Obstet Gynecol. 2009; 200(3):1-260. English
22. Leung AS. [Perinatal outcome in hypothyroid pregnancies]. Obstet Gynecol.1993; 81(3): 349—53. English
23. Mandel SI. [Are detection and treatment of thyroid insufficiency in pregnancy feasible?] Thyroid. 2005; 15(1): 44—53. English
24. Mannisto T. [Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population.] Thyroid. 2011; 21(3): 291—298. English
25. Marqusee E. [Thyroiditis after pregnancy loss]. I Clin Endocrinol Metab.1997; 82 (8): 2455—7. English
26. McClain MR. [FaSTER Research Consortium. Sequential firstand second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study]. Am I Obstet Gynecol. 2008; 199(2): 1-129. English
27. Negro R. [Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications]. I Clin Endocrinol Metab. 2006; 91(7): 2587—2591. English
28. Negro R. [Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy]. I Clin Endocrinol Metab. 2010; 95(9): 44—48. English
29. Panesar NS. [Reference intervals for thyroid hormones in pregnant Chinese women]. Ann Clin Biochem. 2001; 38: 329 —332. English
30. Pearce EN. [Thyroiditis.] N Engl I Med. 2003; 348(26): 2646—2655. English
31. Pearce EN. [Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use] Endocr Pract. 2008; 14(1): 33—39. English
32. Pittas AG, Lee SL, authors; Hall IE, Niemann LK, editors. [Evaluation of thyroid function. Handbook of diagnostic endocrinology]. Humana Press Inc; Totowa. New Iersey. 2003; 112. English
33. Prummel MF. [Thyroid autoimmunity and miscarriage]. Eur I Endocrinol. 2004; 150(6): 751—755. English
34. Roti E. [Placental inner ring iodothyronine deiodination: a mechanism for decreased passage of T4 and T3 from mother to fetus].Trans Assoc Am Physicians.1981; 94: 183—189. English
35. Spencer C. [Thyroid reference ranges in pregnancy: studies on an iodine sufficient cohort]. Thyroid. 2005; 15 (1): 16. English
36. Stagnaro-Green A. [American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum]. Thyroid. 2011; 21(10): 1081—1125. English
37. Stagnaro-Green A. [The thyroid and pregnancy: a novel risk factor for very preterm delivery]. Thyroid. 2005; 15(4): 351— 357. English
38. Stagnaro-Green A. [Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies]. IAMA. 1990; 264(11): 1422— 1425. English
39. Thangaratinam S. [Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence]. BMI. 2011; 342: 2616. English
40. Boogaard VD. [Significance of (sub) clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review]. Hum Reprod Update. 2011; 17(5): 605—619. English